The weekly litigation news digest is live. Subscribe now

IP Verse

Recombinant Fsh Including Alpha 2,3- And Alpha 2,6-Sialylation - EP3144318

The patent EP3144318 was granted to Ferring on Sep 23, 2020. The application was filed on Apr 16, 2009 under application number EP16194925A. The patent is currently recorded with a legal status of "Opposition Rejected".

EP3144318

FERRING
Application Number
EP16194925A
Filing Date
Apr 16, 2009
Status
Opposition Rejected
Sep 6, 2024
Publication Date
Sep 23, 2020
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
ARES TRADINGMar 25, 2021WEICKMANN & WEICKMANN PARTMBBADMISSIBLE

Patent Citations (14) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
OPPOSITIONEP2808340
OPPOSITIONEP3144318
OPPOSITIONUS5541083
OPPOSITIONUS5994128
OPPOSITIONWO0067778
OPPOSITIONWO03035686
OPPOSITIONWO2005080585
OPPOSITIONWO2009127826
OPPOSITIONWO2012017058
OPPOSITIONWO2012168680
OPPOSITIONWO9700326
OPPOSITIONWO9831826
SEARCHWO03035686
SEARCHWO2012016576

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents